The recent challenges in global distribution have highlighted the necessity of securing essential medications like Ivermectin. Trusting on overseas producers exposes nations to potential vulnerabilities, including transportation delays, cost fluctuations, and even political threats. Transitioning towards domestic procurement of Ivermectin offers a